We are live on
!
Find out more
VP
venBio Partners Portfolio holdings
AUM
$281M
1-Year Est. Return
261.03%
This Fund
S&P 500
This Quarter
Est. Return
-1.57%
1 Year Est. Return
+261.03%
3 Year Est. Return
+648.19%
5 Year Est. Return
+623.84%
10 Year Est. Return
–
AUM
$211M
AUM Growth
-$14.6M
(-6.5%)
Cap. Flow
$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKRO
1
DELISTED
Akero Therapeutics
AKRO
| $90M | 42.68% |
3,954,858
| – | – |
|
|
TPTX
2
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $50.4M | 23.91% |
1,340,265
| – | – |
|
3
Precision BioSciences
DTIL
$218M
| $35.8M | 16.98% |
142,171
| – | – |
|
|
APLS
4
DELISTED
Apellis Pharmaceuticals
APLS
| $24.1M | 11.43% |
1,000,000
| – | – |
|
5
VYNE Therapeutics
VYNE
$25.7M
| $6.55M | 3.11% |
20,299
| – | – |
|
|
VRNA
6
DELISTED
Verona Pharma
VRNA
| $4M | 1.9% |
875,000
| – | – |
|
Similar funds
OCWP
FFP
BDA
PHC
SA
ACC
NRCM
IP